The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Sangamo Therapeutics Inc

Nasdaq: SGMO
Last

(U.S.) $4.65

Today's change+0.60 +14.81%
Updated March 29 4:00 PM EDT. Delayed by at least 15 minutes.
 

Sangamo Therapeutics Inc

Nasdaq: SGMO
Last

(U.S.) $4.65

Today's change+0.60 +14.81%
Updated March 29 4:00 PM EDT. Delayed by at least 15 minutes.

Sangamo Therapeutics Inc crosses above 200-day moving average

Sangamo Therapeutics Inc closed up sharply Wednesday, rallying (U.S.)$0.60 or 14.81% to (U.S.)$4.65 and crossing above its 200-day moving average. Over the last five days, shares have gained 16.25% and 52.46% year to date. Shares have underperformed the S&P 500 by 32.60% during the last year.

Key company metrics

  • Open(U.S.) $4.25
  • Previous close(U.S.) $4.05
  • High(U.S.) $4.75
  • Low(U.S.) $4.15
  • Bid / Ask(U.S.) $4.65 / (U.S.) $4.75
  • YTD % change+52.46%
  • Volume1,445,472
  • Average volume (10-day)422,456
  • Average volume (1-month)647,524
  • Average volume (3-month)793,144
  • 52-week range(U.S.) $2.65 to (U.S.) $7.60
  • Beta3.16
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$1.02
Updated March 29 4:00 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue9344
Total other revenue--------
Total revenue9344
Gross profit--------
Total cost of revenue--------
Total operating expense19223121
Selling / general / administrative55115
Research & development14171915
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-10-19-27-17
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-10-19-27-16
Income after tax-10-19-27-16
Income tax, total0000
Net income-10-19-27-16
Total adjustments to net income--------
Net income before extra. items-10-19-27-16
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-10-19-27-16
Inc. avail. to common incl. extra. items-10-19-27-16
Diluted net income-10-19-27-16
Dilution adjustment--------
Diluted weighted average shares71717070
Diluted EPS excluding extraordinary itemsvalue per share-0.14-0.27-0.38-0.23
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share-0.14-0.27-0.38-0.23